Bibliography
- KERLIKOWSKE K: The mammogram that cried Wolfe. N. Engl. J. Med. (2007) 356(3):297-300.
- XIA G, KUMAR SR, MASOOD R et al.: EphB4 expression and biological significance in prostate cancer. Cancer Res. (2005) 65(11):4623-4632.
- KERTESZ N, KRASNOPEROV V, REDDY R et al.: The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4–EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood (2006) 107(6):2330-2338.
- KNUDSEN KE: The cyclin D1b splice variant: an old oncogene learns new tricks. Cell Div. (2006) 24(1):15.
- ZHENG SL, JU JH, CHANG BL et al.: Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Cancer Res. (2006) 66(1):69-77.
- CERVEIRA N, RIBEIRO FR, PEIXOTO A et al.: TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia (2006) 8(10):826-832.
- SHAND RL, GELMANN EP: Molecular biology of prostate-cancer pathogenesis. Curr. Opin. Urol. (2006) 16(3):123-131.
- FRIGOLA J, SONG J, STIRZAKER C et al.: Epigenetic remodelling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat. Genet. (2006) 38(5):504-506.
- SHACKLETON M, VAILANT F, SIMPSON KJ et al.: Generation of a functional mammary gland from a single stem cell. Nature (2006) 439(7072):84-88.
- STINGL J, EIREW P, RICKETSON I et al.: Purification and unique properties of mammary epithelial stem cells. Nature (2006) 439(7079):993-997.
- TAYLOR RA, COWIN PA, CUNHA GR et al.: Formation of human prostate tissue from embryonic stem cells. Nat. Methods (2006) 3(3):179-181.
- GLINSKY GV, BEREZOVSKA O, GLINSKII AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. (2005) 115(6):1503-1521.
- ALBERTELLI MA, SCHELLER A, BROGLEY M et al.: Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol. Endocrinol. (2006) 20(6):1248-1260.
- MIYAKE H, HARA I, FUJISAWA M et al.: The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer. Expert Opin. Investig. Drugs (2006) 15(5):507-517.
- ROCCHI P, BERALDI E, ETTINGER S et al.: Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Cancer Res. (2005) 65(23):11083-11093.
- BEMIS DL, KATZ AE, BUTTYAN R: Clinical trials of natural products as chemopreventive agents for prostate cancer. Expert Opin. Investig. Drugs (2006) 15(10):1191-1200.